MedTrace Logo

Evaluation of Performances and Safety of the Medical Device Blueback® Physio for Patients With Chronic Low Back Pain

NCT04592094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2023-04-12

No results posted yet for this study

Summary

The main objective of this clinical investigation is to show the superiority of a rehabilitation based on the use of Blueback® Physio compared to a rehabilitation without the use of Blueback® Physio in terms of reducing the time needed for a patient to control the voluntary contraction of the transversus abdominal muscle and to return to autonomy.

Conditions

  • Low Back Pain, Recurrent

Interventions

DEVICE

Blueback® Physio

Blueback® Physio is monitoring the activation level of the transversus abdominis muscle in real time during the exercises

Sponsors & Collaborators

  • Slb Pharma

    collaborator OTHER

  • Blueback

    lead INDUSTRY

Principal Investigators

  • Benjamin MARGO, MD · Centre Médical et Pédagogique de Beaulieu

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2022-12-07
Completion
2022-12-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04592094 on ClinicalTrials.gov